Ascentage Pharma Group International (AAPG) Other Accumulated Expenses: 2024-2025
- Ascentage Pharma Group International's Other Accumulated Expenses was N/A to $34.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $34.5 million, marking a year-over-year change of. This contributed to the annual value of $35.4 million for FY2024, which is 82.91% down from last year.
- Per Ascentage Pharma Group International's latest filing, its Other Accumulated Expenses stood at $34.5 million for Q2 2025, which was down 2.50% from $35.4 million recorded in Q4 2024.
- Over the past 5 years, Ascentage Pharma Group International's Other Accumulated Expenses peaked at $35.4 million during Q4 2024, and registered a low of $34.5 million during Q2 2025.
- For the 2-year period, Ascentage Pharma Group International's Other Accumulated Expenses averaged around $34.9 million, with its median value being $34.9 million (2025).
